PGD (Preimplantation Genetic Diagnosis)

Our specialty has come a long way in the last 30 years dramatically improving birth rates but also expanding towards the prevention and diagnosis of genetic abnormalities and thus simultaneously decreasing the incidence of spontaneous abortions.

A new IVF technique, applied with great success at our center, is called Pre-implantation Genetic Diagnosis (PGD) that allows us to detect genetic defects by biopsy of the embryos before pregnancy occurs.

It is well documented that the primary cause for a miscarriage is due to embryo chromosomal abnormalities. With PGD only healthy embryos are transferred into the mother’s uterus, thus reducing the risk of miscarrying and diminishing the risk of inheriting a genetic abnormality and late pregnancy termination after positive prenatal diagnosis.

Also several studies have determined that approximately 70% of embryos from women of advanced maternal age (>36yo) have chromosomal abnormalities, resulting in implantation failure, a higher risk of miscarriage or the birth of a child with genetic abnormality (e.g. Down syndrome).

PGD makes it possible to select top quality “healthy embryos” thus significantly improving pregnancy rates, reducing miscarriage rates, and decreases the chance of a chromosomally abnormal pregnancy.

The Gynecologic Center for Reproduction and Genetics is the first in Greece and one of the few in Europe to perform PGD in IVF. Our physicians and scientists combine the necessary expertise in assisted reproduction and molecular genetics to maintain an active and successful PGD program with over 10 years of experience.